BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak syndrome.

BLOC-1 BLOC1S5 Hermansky–Pudlak syndrome albinism pathogenic variant

Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
10 2020
Historique:
received: 04 05 2020
accepted: 04 06 2020
revised: 03 06 2020
pubmed: 23 6 2020
medline: 28 4 2021
entrez: 23 6 2020
Statut: ppublish

Résumé

Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, excessive bleeding, and often additional symptoms. Variants in ten different genes have been involved in HPS. However, some patients lack variants in these genes. We aimed to identify new genes involved in nonsyndromic or syndromic forms of albinism. Two hundred thirty albinism patients lacking a molecular diagnosis of albinism were screened for pathogenic variants in candidate genes with known links to pigmentation or HPS pathophysiology. We identified two unrelated patients with distinct homozygous variants of the BLOC1S5 gene. Patients had mild oculocutaneous albinism, moderate bleeding diathesis, platelet aggregation deficit, and a dramatically decreased number of platelet dense granules, all signs compatible with HPS. Functional tests performed on platelets of one patient displayed an absence of the obligate multisubunit complex BLOC-1, showing that the variant disrupts BLOC1S5 function and impairs BLOC-1 assembly. Expression of the patient-derived BLOC1S5 deletion in nonpigmented murine Bloc1s5 Mutation of BLOC1S5 is disease-causing, and we propose that BLOC1S5 is the gene for a new form of Hermansky-Pudlak syndrome, HPS-11.

Identifiants

pubmed: 32565547
doi: 10.1038/s41436-020-0867-5
pii: S1098-3600(21)00754-1
pmc: PMC7529931
mid: NIHMS1609960
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1613-1622

Subventions

Organisme : NEI NIH HHS
ID : R01 EY015625
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Seward SL Jr, Gahl WA. Hermansky–Pudlak syndrome: health care throughout life. Pediatrics. 2013;132:153–160.
doi: 10.1542/peds.2012-4003
Delevoye C, Marks MS, Raposo G. Lysosome-related organelles as functional adaptations of the endolysosomal system. Curr Opin Cell Biol. 2019;59:147–158.
doi: 10.1016/j.ceb.2019.05.003
Bowman SL, Bi-Karchin J, Le L, Marks MS. The road to LROs: insights into lysosome-related organelles from Hermansky–Pudlak syndrome and other rare diseases. Traffic. 2019;20:404–435.
doi: 10.1111/tra.12646
Nazarian R, Huizing M, Helip-Wooley A, Starcevic M, Gahl WA, Dell’Angelica EC. An immunoblotting assay to facilitate the molecular diagnosis of Hermansky–Pudlak syndrome. Mol Genet Metab. 2008;93:134–144.
doi: 10.1016/j.ymgme.2007.09.001
Montoliu L, Marks MS. A new type of syndromic albinism associated with mutations in AP3D1. Pigment Cell Melanoma Res. 2017;30:5–7.
doi: 10.1111/pcmr.12543
Montoliu L, Grønskov K, Wei AH, et al. Increasing the complexity: new genes and new types of albinism. Pigment Cell Melanoma Res. 2014;27:11–18.
doi: 10.1111/pcmr.12167
Arveiler B, Lasseaux E, Morice-Picard F. Clinical and genetic aspects of albinism. Presse Med. 2017;46:648–654.
doi: 10.1016/j.lpm.2017.05.020
Lasseaux E, Plaisant C, Michaud V, et al. Molecular characterization of a series of 990 index patients with albinism. Pigment Cell Melanoma Res. 2018;31:466–474.
doi: 10.1111/pcmr.12688
Arveiler B, Michaud V, Lasseaux E. Albinism: an underdiagnosed condition. J Dermatol Invest. 2019. https://doi.org/10.1016/j.jid.2019.12.010 [Epub ahead of print].
Morice-Picard F, Lasseaux E, Cailley D, et al. High-resolution array-CGH in patients with oculocutaneous albinism identifies new deletions of the TYR, OCA2, and SLC45A2 genes and a complex rearrangement of the OCA2 gene. Pigment Cell Melanoma Res. 2014;27:59–71.
doi: 10.1111/pcmr.12173
Setty SRG, Tenza D, Truschel ST, et al. BLOC-1 is required for cargo-specific sorting from vacuolar early endosomes toward lysosome-related organelles. Mol Biol Cell. 2007;18:768–780.
doi: 10.1091/mbc.e06-12-1066
Sviderskaya EV, Hill SP, Evans-Whipp TJ, et al. p16(Ink4a) in melanocyte senescence and differentiation. J Natl Cancer Inst. 2002;94:446–454.
doi: 10.1093/jnci/94.6.446
Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7:1063–1066.
doi: 10.1038/sj.gt.3301206
Meng R, Wang Y, Yao Y, et al. SLC35D3 delivery from megakaryocyte early endosomes is required for platelet dense granule biogenesis and is differentially defective in Hermansky–Pudlak syndrome models. Blood. 2012;120:404–414.
doi: 10.1182/blood-2011-11-389551
Dennis MK, Delevoye C, Acosta-Ruiz A, et al. BLOC-1 and BLOC-3 regulate VAMP7 cycling to and from melanosomes via distinct tubular transport carriers. J Cell Biol. 2016;214:293–308.
doi: 10.1083/jcb.201605090
Delevoye C, Hurbain I, Tenza D, et al. AP-1 and KIF13A coordinate endosomal sorting and positioning during melanosome biogenesis. J Cell Biol. 2009;187:247–264.
doi: 10.1083/jcb.200907122
Li W, Zhang Q, Oiso N, et al. Hermansky–Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet. 2003;35:84–89.
doi: 10.1038/ng1229
Morgan NV, Pasha S, Johnson CA, et al. A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky–Pudlak syndrome (HPS8). Am J Hum Genet. 2006;78:160–166.
doi: 10.1086/499338
Badolato R, Prandini A, Caracciolo S, et al. Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome. Blood. 2012;119:3185–3187.
doi: 10.1182/blood-2012-01-404350
Huizing M, Malicdan MCV, Wang JA, et al. Hermansky–Pudlak syndrome: mutation update. Hum Mutat. 2020;41:543–580.
doi: 10.1002/humu.23968
Zhang Q, Li W, Novak EK, et al. The gene for the muted (mu) mouse, a model for Hermansky–Pudlak syndrome, defines a novel protein which regulates vesicle trafficking. Hum Mol Genet. 2002;11:697–706.
doi: 10.1093/hmg/11.6.697
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.
doi: 10.1038/gim.2015.30
Dawood BB, Lowe GC, Lordkipanidze M, et al. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood. 2012;120:5041–5049.
doi: 10.1182/blood-2012-07-444281
Falcon-Perez JM, Starcevic M, Gautam R, Dell’Angelica EC. BLOC-1, a novel complex containing the pallidin and muted proteins involved in the biogenesis of melanosomes and platelet dense granules. J Biol Chem. 2002;277:28191–28199.
doi: 10.1074/jbc.M204011200
Moriyama K, Bonifacino JS. Pallidin is a component of a multi-protein complex involved in the biogenesis of lysosome-related organelles. Traffic. 2002;3:666–677.
doi: 10.1034/j.1600-0854.2002.30908.x
Starcevic M, Dell’Angelica EC. Identification of snapin and three novel proteins (BLOS1, BLOS2 and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1). J Biol Chem. 2004;279:28393–28401.
doi: 10.1074/jbc.M402513200
Bryan MM, Tolman NJ, Simon KL, et al. Clinical and molecular phenotyping of a child with Hermansky–Pudlak syndrome-7, an uncommon genetic type of HPS. Mol Genet Metab. 2017;120:378–383.
doi: 10.1016/j.ymgme.2017.02.007
Meng R, Wu J, Harper DC, et al. Defective release of a granule and lysosome contents from platelets in mouse Hermansky–Pudlak syndrome models. Blood. 2015;125:1623–1632.
doi: 10.1182/blood-2014-07-586727
Novak EK, Hui SW, Swank RT. Platelet storage pool deficiency in mouse pigment mutations associated with seven distinct genetic loci. Blood. 1984;63:536–544.
doi: 10.1182/blood.V63.3.536.536
Reddington M, Novak EK, Hurley E, Medda C, McGarry MP, Swank RT. Immature dense granules in platelets from mice with platelet storage pool disease. Blood. 1987;69:1300–1306.
doi: 10.1182/blood.V69.5.1300.1300
Pu J, Schindler C, Jia R, Jarnik M, Backlund P, Bonifacino JS. BORC, a multisubunit complex that regulates lysosome positioning. Dev Cell. 2015;33:176–188.
doi: 10.1016/j.devcel.2015.02.011
Snouwaert JN, Church RJ, Jania L, et al. A mutation in the Borcs7 subunit of the lysosome regulatory BORC complex results in motor deficits and dystrophic axonopathy in mice. Cell Rep. 2018;24:1254–1265.
doi: 10.1016/j.celrep.2018.06.118

Auteurs

Perrine Pennamen (P)

Rare Diseases, Genetics and Metabolism, INSERM U1211, University of Bordeaux, Bordeaux, France.
Molecular Genetics Laboratory, Bordeaux University Hospital, Bordeaux, France.

Linh Le (L)

Dept. of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, USA.
Department of Pathology, Laboratory Medicine and Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Cell and Molecular Biology Graduate Group, University of Pennsylvania, Philadelphia, PA, USA.

Angèle Tingaud-Sequeira (A)

Rare Diseases, Genetics and Metabolism, INSERM U1211, University of Bordeaux, Bordeaux, France.

Mathieu Fiore (M)

Laboratoire d'Hématologie, CHU de Bordeaux, Bordeaux, France.
Reference Center for Platelet Disorders, CHU de Bordeaux, Pessac, France.

Anne Bauters (A)

Hémostase et Transfusion CHU Lille, Lille, France.

Nguyen Van Duong Béatrice (N)

Service d'Ophtalmologie Pédiatrique, Hôpital Saint-Vincent de Paul, Lille, France.

Valentine Coste (V)

Service d'Ophtalmologie, CHU de Bordeaux, Bordeaux, France.

Jean-Claude Bordet (JC)

Laboratoire d'Hématologie, CHU Lyon, Lyon, France.

Claudio Plaisant (C)

Molecular Genetics Laboratory, Bordeaux University Hospital, Bordeaux, France.

Modibo Diallo (M)

Rare Diseases, Genetics and Metabolism, INSERM U1211, University of Bordeaux, Bordeaux, France.

Vincent Michaud (V)

Molecular Genetics Laboratory, Bordeaux University Hospital, Bordeaux, France.

Aurélien Trimouille (A)

Rare Diseases, Genetics and Metabolism, INSERM U1211, University of Bordeaux, Bordeaux, France.
Molecular Genetics Laboratory, Bordeaux University Hospital, Bordeaux, France.

Didier Lacombe (D)

Rare Diseases, Genetics and Metabolism, INSERM U1211, University of Bordeaux, Bordeaux, France.
Molecular Genetics Laboratory, Bordeaux University Hospital, Bordeaux, France.

Eulalie Lasseaux (E)

Molecular Genetics Laboratory, Bordeaux University Hospital, Bordeaux, France.

Cédric Delevoye (C)

Institut Curie, PSL Research University, CNRS, UMR144, Structure and Membrane Compartments, Paris, France.
Institut Curie, PSL Research University, CNRS, UMR144, Cell and Tissue Imaging Facility (PICT-IBiSA), Paris, France.

Fanny Morice Picard (FM)

Service de Dermatologie, CHU de Bordeaux, Bordeaux, France.

Bruno Delobel (B)

Centre de Génétique Chromosomique, GHICL, Hôpital Saint Vincent de Paul, Lille, France.

Michael S Marks (MS)

Dept. of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, USA.
Department of Pathology, Laboratory Medicine and Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Benoit Arveiler (B)

Rare Diseases, Genetics and Metabolism, INSERM U1211, University of Bordeaux, Bordeaux, France. benoit.arveiler@chu-bordeaux.fr.
Molecular Genetics Laboratory, Bordeaux University Hospital, Bordeaux, France. benoit.arveiler@chu-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH